
Rapid COVID Tests Are Coming to Stores Near You
Companies backed by millions in public and private cash are racing to bring the tests to market
Companies backed by millions in public and private cash are racing to bring the tests to market
Former CDC director Robert Redfield says he believes in a lab leak—but offers no evidence. The odds are against his notion
The pandemic has spotlighted ways to make clinical trials easier on patients and better for science, a heart drug researcher says
We each have more power to be a science communicator than we realize
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Antibodies can change to counter new forms of the shape-shifting virus, research hints
Scientists say the conclusions make sense but note that supporters of the lab-leak theory are unlikely to be satisfied
Pharmaceutical companies are starting clinical trials in young children and adolescents, but they must balance speed and safety
Pandemic highlights for the week
Today we bring you the third episode in a new podcast series: COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
A now familiar 21st-century scenario of circumventing public-health strictures played out as well at the beginning of the 20th century
Undercounting or ignoring cases of the disease on the continent could lead to new variants that might derail efforts to end the pandemic
SARS-CoV-2 may be settling into a limited set of mutations
Differences in life expectancy, car ownership and language may contribute to the racial and ethnic disparities
Human behavior and social inequity are huge confounding factors
Pandemic highlights for the week
Willingness is rising, even among skeptical groups, at a time when there are still not enough doses to go around
Uptake by patients and physicians has been low in the U.S. even though some therapies have been authorized for months
The decline suggests the vaccine is having an effect even though workers have been slower to take it than residents
Pandemic highlights for the week
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account